Global Health Richard J. Derman, M.D. MPH Chair, Department of Obstetrics and Gynecology, Christiana Care Director, Institute for Women and Children’s.

Slides:



Advertisements
Similar presentations
Global Network for Womens and Childrens Health Research Resuscitation: How to Save One Million Lives Per Year Albert Manasyan, MD; Wally Carlo, MD and.
Advertisements

How Gender Impacts Safe Motherhood
FIGO’s Ten Year Commitment to PPH Prevention and Treatment
MATERNAL HEALTH Some technical aspects ANC, Delivery Care and PNC
Preventing PPH: Community Based Distribution of Misoprostol Harshad Sanghvi Vice President & Medical Director, Jhpiego.
REDUCING MATERNAL AND NEONATAL MORTALITY IN MOZAMBIQUE THE CHALLENGE IN THE NEW MILLENIUM.
1 US and Russia Scientific Forum Meeting November 17, 2011 Postpartum Hemorrhage: The Leading Cause of Maternal Mortality Richard J. Derman, MD, MPH Chair,
Postpartum Hemorrhage Prevention and Treatment in Africa: Using Misoprostol at Community Level Ndola Prata, MD, MSc Africa Regional Meeting on Interventions.
Pathfinder Continuum of Care for Addressing Post-Partum Hemorrhage (PPH) Dr. Abdelhadi Eltahir, MD, MPH, Senior Advisor for Maternal and Newborn Health,
Reducing Maternal Mortality Due to Postpartum Hemorrhage (PPH)
Maternal Interventions What is new, what is on the horizon Fernando Althabe Institute for Clinical Effectiveness and Health Policy Buenos Aires, Argentina.
1 Better health processes and outcomes: How do we get there? Maina Boucar, MD, MPH USAID – Applying Science to Strengthen and Improve Systems Regional.
Use of Oxytocin as Part of Active Management of Third Stage of Labor among Healthcare Providers in Northeast Argentina Connie Nguyen, MPH Candidate 2012.
ADDING IT UP The costs and benefits of investing in family planning and maternal and newborn health.
EFFORTS TO PREVENT MATERNAL AND NEWBORN MORBIDITY AND MORTALITY IN KISARAWE DR. M.O. KISANGA KISARAWE INTRODUCTION Kisarawe District is among the seven.
1 |1 | Making Pregnancy Safer UN Human Rights Council Session 14 4 th June 2010 Department of Making Pregnancy Safer Dr. Maurice Bucagu Sachiyo Yoshida.
Misoprostol for PPH: An Update on Gynuity’s collaborative body of research An Update: March 2008.
Towards National Impact of PPH Prevention: Bangladesh Experience Prof. Dr. Shah Monir Hossain Director General Directorate General of Health Services Ministry.
Community interventions; Physiological management of the third stage of labour. Karen Guilliland CEO New Zealand College of Midwives ICM Board Member.
Umbilical cord clamping in term deliveries: the RCOG perspective Dr Anna David Reader and Consultant in Obstetrics and Maternal Fetal Medicine UCL Institute.
Addressing the Challenge of Neonatal Mortality
PRESENTATION ON SAFETY ISSUES RELEVANT TO HOME BIRTHS AND THE PROFESSIONALS WHO PROVIDE MATERNITY CARE SEPTEMBER 20, 2012 The Maryland Chapter of the American.
Adapted from JHPIEGO. Active Management of the Third Stage of Labor: Advances in Maternal and Neonatal Health. Available at:
The Role of Midwives in MCH 17 th of February, 2009 Alison Lindner BSN, CNM, MPH.
1 EssentialPostpartum and andNewborn Care Care MCH in Developing Countries January 24, 2008.
A Comparative study of maternal mortality between Al-Abasia Tagali and Juba by Mahasin Hamed Haj Elsiddig.
Factors Affecting Maternal Mortality (MM) in Turkey and in the World Dr. Yeşim YASİN Spring-2014.
Policies for einc* care. 3.4 million pregnancies occur every year 11 mothers die of pregnancy - related causes everyday Leading cause of maternal deaths:
Maternal Mortality & the MDGs Deborah Maine Professor, International Health Boston University, School of Public Health.
Skilled attendant at birth mDG 5, target 5A, Indicator 5.2
LESSON 13.7: MATERNAL/CHILD HEALTH Module 13: Global Health Obj. 13.7: Explain the risk factors and causes for maternal and child health problems.
Challenges of meeting MDG4 and MDG 5 in Bangladesh Prof. Kishwar Azad Project Director DAB-Perinatal Care Project.
Presented by: Jennifer Bryce Institute for International Programs Johns Hopkins Bloomberg School of Public Health Mortality and Coverage: Where are we.
AUDIT OF MATERNAL DEATHS USING LONGITUDINAL DATA – CASE OF RUFIJI HDSS By Illah Evance.
Child Health: How Have We Been Doing; Where to Now? An Update on MDG 4 and 5: Maternal and Child Health By Dr. Mickey Chopra, Chief, Health and Associate.
Misoprostol for the Prevention of Postpartum Hemorrhage Lisa J. Thomas, MD, FACOG Women’s Commission for Refugee Women and Children.
Active Management of the Third Stage of Labor Name of presenter Prevention of Postpartum Hemorrhage Initiative (POPPHI) Project PATH.
PPH Prevention and Management at Health Facilities Jeffrey M. Smith Asia Regional Technical Director AME Regional Meeting Bangkok March 2010.
Maternal mortality rate in Yazd-Iran during 10 years ( ) DR.Karimi Zarchi M Gynecological oncology felloship, shahid sadoughi university of Medical.
Improving Maternal Health in Afghanistan Suraya Dalil, MD, MPH Minister of Public Health Washington, DC April 23, 2012.
WHO Recommendations for the Prevention of Postpartum Haemorrhage Results from a WHO Technical Consultation – October 18-20, 2006 Deborah Armbruster, POPPHI/PATH.
Non-medical factors related to maternal mortality Birgitta Essén, MD, associate professor Senior Lecturer in International Maternal Health Care Department.
11 New Sexual and Reproductive Health Guidelines and Technologies Sharon Phillips, Lisa Thomas, Lale Say 31 May 2013.
SOCIAL OBSTETRICS Defined as the study of the interplay of social and environmental factors and human reproduction going back to preconceptional.
Overcoming provider barriers to introduction and sustainability of AMTSL at facilities Susheela M. Engelbrecht PATH / Oxytocin Initiative.
New Frontiers in Newborn Health: Stephen Wall, MD SM Senior Research Manager Saving Newborn Lives Save the Children.
Introduction Millennium Development Goal-4 for child survival cannot be met without substantial reductions in neonatal mortality (Lawn JE et al. Lancet.
04_DirectorReport_PCC/1 9/2004 Rita Kabra_/1 Access to essential medicines for Maternal and Newborn Health Dr Rita Kabra Making Pregnancy Safer WHO/EDM.
Taking PPH prevention to the community in Guatemala with oxytocin in Uniject Ministry of Health of Guatemala National Program for Sexual and Reproductive.
ANE and E & E SOTA Maternal and Neonatal Mortality October 10, 2002.
Millennium Development Goal 4:
Overview of Study Management of the Third Stage of Labor In Uganda.
ALSO Korogwe 2009 Causes of Maternal and Neonatal Deaths Why mothers and newborns die.
1 |1 | Africa Regional Meeting on Interventions for Impact in Essential Maternal and Newborn Care, Addis Ababa, Feb 21, 2011 WHO Recommendations for the.
MCHIP Strategy for Accelerating Scale Up of Interventions to Prevent and Treat Postpartum Hemorrhage 1 20 Nov 2009 Koki Agarwal Director MCHIP Jhpiego.
Reproductive Health class#2 Safe motherhood. Women’s Health Key facts.
International SBCC Summit
Postpartum hemorrhage (PPH) is a leading cause of maternal morbidity and mortality worldwide Prevention of PPH requires early recognition and intervention,
Research to evaluate components of AMTSL POPPHI/USAID/WHO Istanbul, Turkey, 4-5 December 2007.
Overview: Maternal and Child Health in Underdeveloped Countries (or: The World is NOT Flat) HServ/Epi 544 Winter Term 2007.
To AMTSL or Not to AMTSL: That is the Question Deborah Armbruster, Senior Maternal Health and Newborn Advisor Bureau for Global Health, USAID CSHGP’s Partners.
MANDATE Maternal and Neonatal Directed Assessment of Technology GBCHealth November 29, 2011.
Maternal Mortality Assistant Professor Dr. Batool A. Gh. Yassin Depart. Of Community & family Medicine Baghdad College of Medicine 2014.
A New Tool for Saving Women’s Lives in Nigeria: The Potential of the Non-pneumatic Anti-Shock Garment Turan JM, Ojengbede O, Butrick E, Bello OM, Awwal.
Emergency Obstetric and Newborn Care (EmONC)
MOVING TO ACTION: Identifying Responses.
Reducing global mortality of children and newborns
Maternal Health in Zambia
Management of the 3rd stage of Labor
Presentation transcript:

Global Health Richard J. Derman, M.D. MPH Chair, Department of Obstetrics and Gynecology, Christiana Care Director, Institute for Women and Children’s Health Research Professor, Obstetrics and Gynecology Thomas Jefferson University

Why International Research?  99% of maternal deaths occur in developing countries  23% of pregnant women have no access to antenatal care  39% of women deliver without a skilled birth attendant  The death of a women is associated with major negative outcomes for living children  The same conditions that kill women in the developing world are leading causes of mortality and morbidity in the U.S. Maternal Health Task Force, 2009

Why Do Women Die? 530,000 maternal deaths annually  Postpartum hemorrhage  Eclampsia  Infection/Septic Abortion

PPH’s Contribution to Mortality and Morbidity  The single most important cause of maternal death worldwide.  At least 1/4 of all worldwide maternal deaths (> 530,000) are due to PPH. (> 530,000) are due to PPH.  14,000,000 cases of pregnancy-related hemorrhage each year with at least 128,000 of these women bleeding to death.  The percentage of all pregnancy-related deaths due to hemorrhage is 19% in the United States.

Global Scenario WHO - UNICEF - UNFPA MaternalDeaths(Number) Maternal Mortality Ratio (deaths per 100,000 live births) Life time risk of maternal death 1 in: India 136, Develope d regions 2,500202,800 World Total 529,

PPH Non-Predictable  Two-thirds of women who hemorrhage have no identifiable risk factors  Similar ratio among PP hemorrhage deaths in US  Women who survive often must receive blood transfusion - ↑ risk of hepatitis or HIV WHO Mother-Baby Package, 1998

Average Interval from Onset to Death  Ruptured uterus24 hrs  Antepartum hemorrhage12 hrs  Postpartum hemorrhage 2 hrs Maine D. Safe Motherhood Programs: Options and Issues, Center for Population & Family Health, Columbia University,1993.

Strategies for Reducing Postpartum Hemorrhage Secondary to Atonic Uterus

Active Management of the Third Stage of Labor  Designed to speed the delivery of the placenta by increasing uterine contractions and thus averting uterine atony (60% reduction in risk)  Components –Administration of uterotonic agent (post cord-clamping) –Placenta delivered by controlled cord traction with counter-traction on the fundus –Uterine massage > delivery of placenta FIGO Joint Statement June, 2004

Active Management of the Third Stage of Labor without Controlled Cord Traction: A Randomized Non-inferiority Controlled Trial  Uterotonic use likely has greatest impact  Concern over controlled cord traction in rural areas among nonphysicians  If not significant change in bleeding, can recommend against the practice and expand AMTSL to lower level providers Gulmezoglu, M, et al., Reproductive Health, 2009 Jan, 6:2. (World Health Organization)

A Randomized Placebo-Controlled Trial of Oral Misoprostol for Prevention of Postpartum Hemorrhage at Four Primary Health Centers of the Belgaum District, Karnataka India  Richard J. Derman, MD, MPH  Bhala Kodkany, MD  V.J. Naik, MD  Ashlesha Patel, MD, MPH  Shiva Goudar, MD  Stacie Geller, PhD  Stanley Edlavitch, PhD

Study Sponsors

Intervention  Misoprostol or Placebo #3, 200 mcg tablets, orally  Administered within 5 minutes of clamping and cutting of the cord and cessation of cord pulsation

Primary Outcome  Objective Measurement of Blood Loss  BRASSS-V ® Blood Collection Drape with Calibrated Receptacle

BRASSS-V Blood Collection Drape with Calibrated Receptacle

Primary Hypothesis Misoprostol administered during the third stage of labor will significantly reduce the incidence of acute postpartum hemorrhage by 50%.

Oral misoprostol in preventing postpartum hemorrhage in resource-poor communities: a randomized controlled trial Lancet 2006; 368: Lancet 2006; 368:

PPH Rates PPH Rates Primary Outcome Misoprostol (n= 812*) n (%) Placebo(n=805) P- valu e PostpartumHemorrhage (blood loss  500 ml) 53 (6.5) 53 (6.5) 97 (12.0) 97 (12.0) Severe Postpartum Hemorrhage (blood loss  1,000 ml) 2 (0.2) 2 (0.2) 10 (1.2) ss 10 (1.2) ss

One case of postpartum hemorrhage was prevented for every 18 women who received Misoprostol  Price now reduced to 12 cents/dose  Registered in 14 countries in Africa and Asia

Postpartum Hemorrhage Rates for Data Review Periods of Randomized Women by Treatment Overall Data Review Periods % PPH MisoprostolPlacebo n=256 n=220 n=254 n=219 n=121 n=119 n=215 n=216 n=811 n=808 Goudar SS, et al., Variation in the postpartum hemorrhage rate in a clinical trial of oral misoprostol. J Matern Fetal Neonatal Med Aug; 21(8):559-64

What Measured Blood Loss Tells Us About Postpartum Bleeding: A systematic review  Prevalence of PPH (>500 ml) 10.55% in 19 studies where blood loss was measured vs. 7.23% with visual estimation  Ongoing debate about changing the definition of PPH – (clinical instability, drop in Hgb of >10% or >750ml) Sloan N, et. al. BJOG, 4/2010

Management of PPH Low Resource Settings Is it more cost effective to prevent or to treat?  Aggressive Treatment of PPH –Misoprostol mcg rectally/sublinguinal –UNIJECT ® - Oxytocin  Prefilled, nonrefillable, sterile  Single dose  Auto-disable syringe PATH – Program for Appropriate Technology in Health

Inflated condom in a kidney tray

Non-inflatable Anti-shock Garment

Reducing Morbidity and Mortality of PPH (Lessons learned from the U.S.)  Team training  Use of simulation laboratories  Rapid response team drills –massive transfusion protocol  Hospitals in lowest quartile of deliveries have mortality/hysterectomy rates  71% Bateman B. et al. Anaes-Analg, 2010.

Newborn Care Training and Perinatal Mortality in Developing Countries  3.7 million neonatal deaths  3.3 million stillbirths (majority fresh stillbirths)  98% occur in developing countries  An evaluation of community-based interventions is needed Carlo W, et al. NEJM Feb 18, 2010

First Breath Trial First Breath Trial  Six country study instituted (DRC, Zambia, India, Pakistan, Guatemala, Argentina)  Train the trainer model  Employed WHO ENC training model –Routine neonatal care –Resuscitation –Thermoregulation –Breast feeding –Skin-to-skin care Carlo W, et al. NEJM Feb 18, 2010

Selected GN Research Advances  “FIRST BREATH”: 30% reduction in the rate of stillbirths following basic training in resuscitation and newborn care for birth attendants.  120,000 births and 3,600 birth attendants trained NEJM, 2010; 362:

Estimated stillbirth numbers by World Region, % Source: Stanton, Lawn et al Lancet % Low and middle income countries Total of 3.2 million (2.5 to 4.1 million)

Reducing Perinatal Mortality in Community Settings  Site-specific findings in Belgaum are consistent with a 30%  in neonatal mortality in Nepal and a similar reduced risk by training TBAs’ in Pakistan.  Reduction in mortality beyond a certain level likely requires access to facility care with emergency preparedness. Goudar, et al., In Press

EMONC The GN is currently conducting a trial employing a package of interventions including:  Home-based lifesaving skills  Training of all birth attendants  Facilitation of transport  Community mobilization  Death audit

Global Network Registry Collection of registry data on maternal and neonatal deaths, allowing for and neonatal deaths, allowing for population-based research, identification of effective interventions and development of evidence-based health care policies. N=160,000

Next Multi-site Study in Concert with WHO Trial of antenatal steroids to reduce mortality among preterm/low birth weight infants in limited-resource settings.

Exposure of Pregnant Women to Indoor Air Pollution (10 sites, 9 countries) Exposure of Pregnant Women to Indoor Air Pollution (10 sites, 9 countries)  Largest survey among pregnant women in developing world  Concerns over cooking with animal dung, crop residue and charcoal  Safety issue relating to open fires indoors  Impact of second hand smoking Data suggests poorer pregnancy outcomes Kadir, MM et al. Acta OB et GYN 2009

Global Alliance on Clean Cook Stoves “NICHD joins the Dept of State, the EPA, the CDC, and other federal partners in supporting this initiatives of the UN Foundation to address the health, environmental, economic, and gender risks associated with the use of solid fuels in traditional cook stoves by about half of world’s population” Guttmacher, A

Conclusion  We know how to reduce maternal and neonatal mortality  Keys to success must incorporate: Education of all birth providers Education of all birth providers Team training Team training Community involvement Community involvement Implementation and dissemination research Implementation and dissemination research